Add-on Acquisition • Software

Voiant Acquires Voxeleron

On April 15, 2025, Voiant acquired software company Voxeleron

Acquisition Context

This is Voiant’s 1st transaction in the Software sector.
This is Voiant’s 3rd transaction in the United States.
This is Voiant’s 1st transaction in Texas.

Explore All 10284 Add-on Acquisition Software Deals - Search the Database Free

M&A Deal Summary
Date	April 15, 2025
Target	Voxeleron
Sector	Software
Buyer(s)	Voiant
Deal Type	Add-on Acquisition

Target Company

Voxeleron

Austin, Texas, United States

Voxeleron is an AI-driven ophthalmic image analysis, offering advanced solutions for applications in medicine, biology, and beyond. Voxeleron's platform provides image analysis software for all ophthalmic imagery, enabling researchers to accelerate clinical research, generate actionable results, and ultimately drive better patient outcomes. Voxeleron was formed in 2010 and is headquartered in Austin, Texas.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Voiant

Waltham, Massachusetts, United States

Category	Company
Founded	1992
Sector	Life Science

DESCRIPTION

Voiant is a provider of imaging core laboratory services and other blinded centralized review services for pharmaceutical and medical device clinical trials. Voiant was founded in 1992 and is based in Waltham, Massachusetts.

Deal Context for Buyer	#
Overall	3 of 3
Sector: Software	1 of 1
Type: Add-on Acquisition	2 of 2
State: Texas	1 of 1
Country: United States	3 of 3
Year: 2025	1 of 1

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2023-09-13	MedQIA Los Angeles, California, United States MedQIA is a global, full service, contract research organization specializing in Quantitative Image Analysis for clinical trials. MedQIA provides a full range of CRO services and handles all aspects of your clinical trial from planning to completion. The company specializes in delivering cutting-edge quantitative imaging biomarkers in Phase I through IV studies for drugs and in medical devices. MedQIA is based in Los Angeles, California.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2023-09-13

MedQIA

Los Angeles, California, United States

MedQIA is a global, full service, contract research organization specializing in Quantitative Image Analysis for clinical trials. MedQIA provides a full range of CRO services and handles all aspects of your clinical trial from planning to completion. The company specializes in delivering cutting-edge quantitative imaging biomarkers in Phase I through IV studies for drugs and in medical devices. MedQIA is based in Los Angeles, California.

Buy

Explore Related M&A Activity

Software M&A - Add-on Acquisition M&A Deals - Texas M&A - United States M&A - 2025 M&A